Celyad SA, formerly Cardio3 Biosciences SA is a Belgium-based drug developing company. The Company develops stem cell-based therapies for cardiovascular disease. The Company focuses on developing regenerative therapies to treat illnesses where cardiac ...

Biotechnology

Celyad

Celyad's headquarters in Mont-Saint-Guibert, Belgium

David Georges

Charles Morris

Hannes Iserentant

An Phan

Serge Goblet

Ami Patel Shah

Marina Udier

Dominic Piscitelli

Christopher Lipuma

Hilde Windels

The Directors at Celyad are responsible for providing strategic oversight and governance to ensure the company effectively develops its stem cell-based therapies for cardiovascular diseases. This team evaluates and approves major initiatives, ensures regulatory compliance, and guides the company's long-term vision to achieve its regenerative therapy objectives.

Directors

The Leadership Team at Celyad plays a crucial role in steering the company's strategic direction and overall operations. Comprised of key executives, including the Chief Medical Officer and Vice Presidents of Finance and Administration, this team focuses on advancing stem cell-based therapies for cardiovascular diseases, ensuring regulatory compliance, managing financial health, and fostering innovation in regenerative medicine. Their collective expertise drives Celyad's mission to improve patient outcomes through novel therapeutic solutions.

Leadership Team

The Research and Development team at Celyad is responsible for advancing stem cell-based regenerative therapies for cardiovascular diseases. They conduct cutting-edge research, develop new treatment protocols, and perform rigorous testing to bring innovative solutions from concept to clinical application.

��

Celyad

Org chart

Board & advisors

Teams

Directors

Leadership Team

Research and Development

Offices

��������

Celyad

Org chart

Board & advisors

Teams

Directors

Leadership Team

Research and Development

Offices

Related companies

��